FEBS LETTERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2019-02-09 124a44c5m26暂无昵称

审稿速度:1.0 | 投稿命中率:25.0
经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试

223 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2021-07-31 ms2000000005051387

偏重的研究方向：药理学
经验分享：请问各位大神药理学方向可以投吗？

74 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2018-09-28 shicongdemao

请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表::
周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表:
周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖

xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖

295 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2021-02-21 ms2205852206988122

请问大家投稿过程大概花了多久啊？

115 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2020-01-06 ms9001418248751590

审稿速度:2.0
经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。

123 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2021-01-13 ms1000001697547505

一周了还在undeegoing initial checking，有朋友是这种情况吗

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2020-08-09 1486d2d3m53暂无昵称

审稿速度:1.0 | 投稿命中率:75.0
经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！

142 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2019-12-03 王肖

啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表:
嗯…很快就说不适合我们然后推荐转febs bio open

田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open

147 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2020-05-27 大猪头

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间

140 0

[GetPortalCommentsPageByObjectIdResponse(id=566571, encodeId=f8d15665e118, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：下午投，晚上秒拒，高效，不耽误事儿，值得一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102e2503488, createdName=124a44c5m26暂无昵称, createdTime=Sat Feb 09 00:00:00 CST 2019, time=2019-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004235, encodeId=dc9e10042359e, content=偏重的研究方向：药理学 经验分享：请问各位大神药理学方向可以投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0335561023, createdName=ms2000000005051387, createdTime=Sat Jul 31 15:46:33 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561543, encodeId=0dbb56154344, content=请问下，新分子，没有任何文献，只做了表型没有机制，能投嘛xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖xs菜 2018-09-17 23:26:00 发表: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, beContent=xs菜 2018-09-17 发表:: 周六投隔一天周一晚上就被拒了原因是没有机制真的拒的很快不拖, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/24/094e712f9aec02e9b8158c2318d70032.jpg, createdBy=49761615477, createdName=shicongdemao, createdTime=Fri Sep 28 00:00:00 CST 2018, time=2018-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926070, encodeId=ff909260e02f, content=请问大家投稿过程大概花了多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70051758206, createdName=ms2205852206988122, createdTime=Sun Feb 21 11:11:12 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856519, encodeId=a0ec856519fa, content=审稿速度:2.0 经验分享：一审40多天，期间催稿一次编辑回复很nice，提出了10几个问题，一个月期限，3周后12月25修回，目前under review.。。等待中。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Mon Jan 06 12:24:13 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916112, encodeId=dbb991611256, content=一周了还在undeegoing initial checking，有朋友是这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc505451720, createdName=ms1000001697547505, createdTime=Wed Jan 13 02:21:49 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807152, encodeId=68b380e15244, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：多亏了这个杂志才能毕业！审稿速度特别快，两周。修改后一周接受。两个月入库被检索。感恩！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08a15294138, createdName=1486d2d3m53暂无昵称, createdTime=Sun Aug 09 22:27:12 CST 2020, time=2020-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580887, encodeId=5cd758088ef3, content=啊。。。我直接投了bioopen....田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6831978229, createdName=王肖, createdTime=Tue Dec 03 00:00:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600633, encodeId=89f060063323, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投了一篇没报太大希望，投稿24h就transfer到FEBS open bio了，速度很快，不耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5dfe2480891, createdName=大猪头, createdTime=Wed May 27 08:54:42 CST 2020, time=2020-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586861, encodeId=536058686125, content=请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, beContent=田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/06/4593c8702bb1ed5ddda5ca24a2929e1b.jpg, createdBy=c4c75258846, createdName=147f9deem35暂无昵称, createdTime=Wed Mar 18 00:00:00 CST 2020, time=2020-03-18, status=1, ipAttribution=)]

2020-03-18 147f9deem35暂无昵称

请问转的话是不是接受比较快？还是审稿流程啥的会快些田田要学习 2019-11-17 00:00:00 发表:
嗯…很快就说不适合我们然后推荐转febs bio open

田田要学习 2019-11-17 00:00:00 发表: 嗯…很快就说不适合我们然后推荐转febs bio open

26 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务